Cargando…

Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice

Nonalcoholic fatty liver disease (NAFLD) is a global epidemic, and there is no standard and efficient therapy for it. Chitosan oligosaccharide (COS) is widely known to have various biological effects, and in this study we aimed to evaluate the liver-protective effect in diet-induced obese mice for a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Minyi, Lyu, Qianqian, Liu, Yujie, Hu, Haiyang, Wang, Shilei, Pan, Chuyue, Duan, Xubin, Gao, Yingsheng, Qi, Lian-wen, Liu, Weizhi, Wang, Lirui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669476/ https://www.ncbi.nlm.nih.gov/pubmed/31269758 http://dx.doi.org/10.3390/md17070391

Ejemplares similares

Low‐molecular weight oligosaccharides from gum tragacanth (Astragalus gossypinus) ameliorate nonalcoholic fatty liver disease (NAFLD) in Wistar male rats
por: Hossein Zadeh, Zahra, et al.
Publicado: (2022)

Erratum to “Low‐molecular weight oligosaccharides from gum tragacanth (Astragalus gossypinus) ameliorate nonalcoholic fatty liver disease (NAFLD) in Wistar male rats”
Publicado: (2023)

Chitosan Oligosaccharide Ameliorates Metabolic Syndrome Induced by Overnutrition via Altering Intestinal Microbiota
por: Wang, Yihua, et al.
Publicado: (2021)

Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD)
por: Chen, Qian, et al.
Publicado: (2017)

Determination of oligosaccharide product distributions of PL7 alginate lyases by their structural elements
por: Zhang, Keke, et al.
Publicado: (2022)

Exploring Effects of Chitosan Oligosaccharides on the DSS-Induced Intestinal Barrier Impairment In Vitro and In Vivo
por: Wang, Yujie, et al.
Publicado: (2021)

Biological Effects and Applications of Chitosan and Chito-Oligosaccharides
por: Guan, Guiping, et al.
Publicado: (2019)

Synergistic effects of black ginseng and aged garlic extracts for the amelioration of nonalcoholic fatty liver disease (NAFLD) in mice
por: Jiang, Guihun, et al.
Publicado: (2021)

Chitosan oligosaccharide ameliorates acute lung injury induced by blast injury through the DDAH1/ADMA pathway
por: Liu, Yun-En, et al.
Publicado: (2018)

Chitin Oligosaccharide and Chitosan Oligosaccharide: Two Similar but Different Plant Elicitors
por: Yin, Heng, et al.
Publicado: (2016)

Effects of Chitosan Oligosaccharides on Human Blood Components
por: Guo, Xi, et al.
Publicado: (2018)

Synthesis of Biocompatible Hydroxyapatite Using Chitosan Oligosaccharide as a Template
por: Wang, Jinyu, et al.
Publicado: (2015)

The Anti-inflammatory Effect of Chitosan Oligosaccharide on Heart Failure in Mice
por: Zhang, Yubiao, et al.
Publicado: (2022)

An Overview of the Protective Effects of Chitosan and Acetylated Chitosan Oligosaccharides against Neuronal Disorders
por: Hao, Cui, et al.
Publicado: (2017)

Gold nanoparticles with chitosan, N-acylated chitosan, and chitosan oligosaccharide as DNA carriers
por: Abrica-González, Paulina, et al.
Publicado: (2019)

Chitosan oligosaccharide inhibits skull resorption induced by lipopolysaccharides in mice
por: Guo, Ke, et al.
Publicado: (2019)

Anti-Obesity Effect of Chitosan Oligosaccharide Capsules (COSCs) in Obese Rats by Ameliorating Leptin Resistance and Adipogenesis
por: Pan, Haitao, et al.
Publicado: (2018)

Chitosan Oligosaccharides Suppress Nuclear Factor-Kappa B Activation and Ameliorate Experimental Autoimmune Uveoretinitis in Mice
por: Hsu, Sheng-Min, et al.
Publicado: (2020)

The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)
por: Carulli, Lucia, et al.
Publicado: (2019)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
por: Drescher, Hannah K., et al.
Publicado: (2019)

Aryl Hydrocarbon Receptor Deficiency in Intestinal Epithelial Cells Aggravates Alcohol-Related Liver Disease
por: Qian, Minyi, et al.
Publicado: (2021)

Tunable Thermo-Responsive Properties of Hydroxybutyl Chitosan Oligosaccharide
por: Chen, Chong, et al.
Publicado: (2022)

Mulberry Fruit Extract Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) through Inhibition of Mitochondrial Oxidative Stress in Rats
por: Yang, Dong Kwon, et al.
Publicado: (2018)

INHIBITORY EFFECT OF CHITOSAN OLIGOSACCHARIDE ON HUMAN HEPATOMA CELLS IN VITRO
por: Liu, Likun, et al.
Publicado: (2017)

Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies
por: Fang, Tingyu, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
por: Di Ciaula, Agostino, et al.
Publicado: (2021)

PIN1, a perspective on genetic biomarker for nonalcoholic fatty liver disease (NAFLD)
por: Wang, Jing-Zhang, et al.
Publicado: (2019)

Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD
por: Wang, Junling, et al.
Publicado: (2016)

Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Del Campo, José A, et al.
Publicado: (2018)

Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
por: Zarghamravanbakhsh, Paria, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
por: Dorairaj, Vicneswarry, et al.
Publicado: (2021)

Chitosan Oligosaccharide Attenuates Nonalcoholic Fatty Liver Disease Induced by High Fat Diet through Reducing Lipid Accumulation, Inflammation and Oxidative Stress in C57BL/6 Mice
por: Tao, Wenjing, et al.
Publicado: (2019)

Preparation of Polyurea Microcapsules by Interfacial Polymerization of Isocyanate and Chitosan Oligosaccharide
por: Yu, Fuqiang, et al.
Publicado: (2021)

Vitamin E succinate-grafted-chitosan/chitosan oligosaccharide mixed micelles loaded with C-DMSA for Hg(2+) detection and detoxification in rat liver
por: Wei, Binghui, et al.
Publicado: (2019)

Beneficial Metabolic Effects of Chitosan and Chitosan Oligosaccharide on Epididymal WAT Browning and Thermogenesis in Obese Rats
por: Wang, Jin, et al.
Publicado: (2019)

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
por: Younossi, Zobair M., et al.
Publicado: (2023)

Anticancer and Anti-Inflammatory Properties of Chitin and Chitosan Oligosaccharides
por: Azuma, Kazuo, et al.
Publicado: (2015)

Preparation of Defined Chitosan Oligosaccharides Using Chitin Deacetylases
por: Bonin, Martin, et al.
Publicado: (2020)

The Microstructure, Antibacterial and Antitumor Activities of Chitosan Oligosaccharides and Derivatives
por: Yu, Dawei, et al.
Publicado: (2022)

Celastrol-conjugated chitosan oligosaccharide for the treatment of pancreatic cancer
por: Zeng, Xiaohu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_deoctbvgt2k8866d3ls1een2o5